Q&A: How do we report alemtuzumab?
APCs Insider, August 14, 2015
Want to receive articles like this one in your inbox? Subscribe to APCs Insider!
Q: Our physicians want to administer a drug that’s new to us called alemtuzumab, with the brand name Lemtrada®. However, we found no information concerning a HCPCS code for reporting this drug. How can we bill Medicare?
A: Alemtuzumab is approved by the FDA for the treatment of relapsing forms of multiple sclerosis. CMS created a new HCPCS level II code for reporting this biological. Q9979 (injection, alemtuzumab, 1 mg) will be a valid HCPCS code for Medicare effective October 1.
Providers will want to be sure that their charge structures are set up to report the appropriate number of units to reflect the amount of the drug administered based on the "per 1 mg" description.
In addition, if alemtuzumab is provided in a single use vial, providers must document in the patient’s medical record any amount of drug that is wasted to support the additional units reported on the claim.
For more information, see Transmittal 3304.
Editor’s note: Denise Williams, RN, CPC-H, seniorvice president of revenue integrity services at Health Revenue Assurance Associates, Inc., in Fort Lauderdale, Florida, answered this question.
Want to receive articles like this one in your inbox? Subscribe to APCs Insider!
Related Products
-
Briefings on APCs
Worried about the complexities of the new rules under OPPS and APCs? Briefings on APCs helps you understand the new rules...
-
HIM Briefings
Guiding Health Information Management professionals through the continuously changing field of medical records and toward a...
-
Briefings on Coding Compliance Strategies
Submitting improper Medicare documentation can lead to denial of fees, payback, fines, and increased diligence from payers...
-
Briefings on HIPAA
How can you minimize the impact of HIPAA? Subscribe to Briefings on HIPAA, your health information management resource for...
-
APCs Insider
This HTML-based e-mail newsletter provides weekly tips and advice on the new ambulatory payment classifications regulations...
Most Popular
- Articles
-
- Don't forget the three checks in medication administration
- Practice the six rights of medication administration
- Q&A: Primary, principal, and secondary diagnoses
- Note similarities and differences between HCPCS, CPT® codes
- OB services: Coding inside and outside of the package
- Skills of effective case managers
- Differentiate between types of wound debridement
- Know the medical gas cylinder storage requirements
- Complications from immobility by body system
- Prevent dehydration with nursing interventions
- E-mailed
-
- Q&A: Backdating an inpatient admission
- Are coroners and medical examiners entitled to receive PHI?
- Differentiate between types of wound debridement
- CVS to pay $2.25 million settlement for patient privacy breaches
- Consider two options for coding Rho(D) immune globulin given in pregnancy
- Joint Commission now allows partially-used oxygen canisters in 'full' rack
- How to use revenue codes with trauma patients
- Hospital Billing from A to Z: 3- and 1-day rules
- HIPAA Q&A: Cameras in patient rooms
- Guidelines for stem cell storage and collection
- Searched
